Clinical Trials Browser

Indomethacin × Gastrointestinal × 90 days × Clear all

NCT01719926 2026-06-04

PIFA

Phase 1 Completed

GastrointestinalGynecologic

Esophageal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT07560566 2026-05-01

SHIELD: Sorafenib Hand-foot Syndrome Inhibition With Pre-Emptive Local Delivery of Topical Indomethacin

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular